All In Biotech

Drug Trial Radar · NCT06785012

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

A Randomized, Double-blind, Multicenter, Placebo-controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-89495120 as Monotherapy in Adult Participants With Major Depressive Disorder (MDD)

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 105 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

105

Actual

Start

Dec 26, 2024

Primary completion

Jun 25, 2026

Study completion Aug 10, 2026

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jan 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).

Conditions

  • Depressive Disorder, Major

Interventions

  • JNJ-89495120Drug

    JNJ-89495120 will be administered.

  • PlaceboDrug

    Placebo will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score to Day 5Time frame: Baseline up to Day 5

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • UAB Huntsville Regional Medical Campus

    Huntsville, Alabama

  • Chandler Clinical Trials

    Chandler, Arizona

  • IMA Clinical Research PC Phoenix

    Phoenix, Arizona

  • Noble Clinical Research

    Tucson, Arizona

  • University of Arizona

    Tucson, Arizona

  • CI Trials

    Bellflower, California

  • Wake Research PRI Encino

    Encino, California

  • National Institute Of Clinical Research

    Garden Grove, California

  • WR-Newport Beach

    Newport Beach, California

  • ATP Clinical Research

    Orange, California

  • Anderson Clinical Research

    Redlands, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Lumos Clinical Research Center LLC

    San Jose, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Inland Psychiatric Medical Group Inc

    Temecula, California

  • Sunwise Clinical Research

    Walnut Creek, California

  • Mountain View Clinical Research

    Denver, Colorado

  • Gulfcoast Medical Research Center

    Fort Myers, Florida

  • The Medici Medical Research

    Hollywood, Florida

  • Advanced Research Institute of Miami

    Homestead, Florida

  • K2 Medical Research

    Maitland, Florida

  • Pharmax Research Clinic Inc

    Miami, Florida

  • Wellness Research Center

    Miami, Florida

  • Best Choice Medical and Research Service

    Pembroke Pines, Florida

  • Interventional Psychiatry of Tampa Bay

    Tampa, Florida

  • Health Synergy Clinical Research

    West Palm Beach, Florida

  • Synexus Clinical Research US Inc

    Atlanta, Georgia

  • iResearch Atlanta LLC

    Decatur, Georgia

  • Accelerated Clinical Research Group LLC

    Snellville, Georgia

  • University of Chicago Medical Center

    Chicago, Illinois

  • Indiana University IU Health

    Indianapolis, Indiana

  • DelRicht Research

    New Orleans, Louisiana

  • CBH Health

    Gaithersburg, Maryland

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • Integrative Clinical Trials LLC

    Brooklyn, New York

  • Patient Priority Clinical Sites LLC

    Cincinnati, Ohio

  • University of Cincinnati

    Cincinnati, Ohio

  • OSU Department of Psychiatry and Behavioral Health

    Columbus, Ohio

  • Paradigm Research Professionals, LLC

    Oklahoma City, Oklahoma

  • University of Pennsylvania

    Philadelphia, Pennsylvania

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.